RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. U.S. Renal Care
U

U.S. Renal Care portfolio

U.S. Renal Care has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $77.5M.
Latest deal: R1 Therapeutics · Mar 17, 2026.
About this page

Its most recent investment on record is R1 Therapeutics's $77.5M Series A round in March 2026, alongside DaVita Venture Group, Abingworth, SymBiosis and 2 others. That company is in Health and bio.

What U.S. Renal Care invests in

How U.S. Renal Care invests

StageDealsCapital in rounds
Series A 1 100%$77.5M

U.S. Renal Care portfolio companies

CompanyRound with U.S. Renal CareTotal raisedLatest raise
RR1 Therapeutics
Health and bio
Series A · $77.5M$158MSep 30, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name U.S. Renal Care. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists U.S. Renal Care, which is a subset of its real portfolio. API: /api/v1/investors/u-s-renal-care (get a free API key). More: the most active VC firms and new venture capital funds.